Minneapolis, Minnesota, United States In 1981 was created Bio-Techne, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Minneapolis. The fund was located in North America if to be more exact in United States.
Among the various public portfolio startups of the fund, we may underline CyVek, ChemoCentryx Among the most popular fund investment industries, there are Health Diagnostics, Medical Device. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Bio-Techne, startups are often financed by OrbiMed, MPM Capital, Kaiser Permanente Ventures. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Jennison Associates, HBM Healthcare Investments AG. In the next rounds fund is usually obtained by HBM Healthcare Investments AG, Glaxo Group, Alta Partners.
The fund was created by Roger C. Lucas Ph.D..
The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2006. The increased amount of exits for fund were in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Bio-Techne performs on 71 percentage points more the average number of lead investments. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies.
Related Funds
| Fund Name | Location |
| American Bailey Ventures | Connecticut, Stamford, United States |
| AVIA | Chicago, Illinois, United States |
| Budge Budge Carbon Ltd | India, Kolkata, West Bengal |
| CB/EM Holdings | - |
| Econocom | France, Ile-de-France, Puteaux |
| Farfetch | England, London, United Kingdom |
| Fuse Capital | Brazil, Rio de Janeiro, Rio De Janeiro |
| Impact Venture | England, London, United Kingdom |
| Inventures | Alberta, Calgary, Canada |
| Kepventure Pte Ltd | - |
| Kli Capital | Canada, Montréal, Quebec |
| Liangjie Touzi | China, Hangzhou, Zhejiang |
| Optiomi Invest | Finland, Helsinki, Southern Finland |
| Rongsheng Venture Capital | - |
| SC Launch | Columbia, South Carolina, United States |
| Twangiza Transaction | - |
| U.S. International Development Finance Corp | District of Columbia, United States, Washington |
| Venture Capital Action Plan | - |
| Zhonghuijin Group | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ChemoCentryx | $17M | 24 Aug 2006 | Mountain View, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ChemoCentryx | $17M | 24 Aug 2006 | Mountain View, California, United States |
